Search results
Added:
3 years ago
History of Mechanical Circulatory Support
The first reported clinical use of a left ventricular assist device (LVAD) was by Liotta and Crawford in 1963. Via a left thoracotomy, an intracorporeal pneumatically driven pump was implanted using left atrial inflow and descending thoracic aortic outflow. Despite the successful implantation, the patient died within a short period of time after the…
View more
Added:
3 years ago
Aims: To assess the clinical and neurohormonal characteristics of patients eligible to sacubitril/valsartan (SV) attending to an outpatient heart failure clinic and describe variables related to SV prescription in real-life heart failure patients.
Design and methods: We collected data from 119 consecutive patients attending our heart failure outpatient clinic between May 2018 and November 2018.
…
View more
Added:
1 year ago
In this short video we asked Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) about the key heart failure highlights of 2022 and his thoughts on what comes next in HF treatment and research.
Recorded at Heart Failure 2022, Madrid.
View more
Added:
3 years ago
Heart failure (HF) is a growing and increasingly important chronic disease of the Western world, occurring in at least 2% of the adult population and rising to 3% in those aged over 75 years. It is characterised by inadequate systemic perfusion due to impairment of the cardiac pump function. Clinical HF is a progressive condition, typically with high morbidity and mortality rates. It therefore…
View more
Added:
3 years ago
Chronic heart failure is the leading cause of hospitalisation in Germany1 and other European countries. It is the result of various cardiovascular diseases, such as myocardial infarction, arterial hypertension and valvular heart diseases. About 50 % of patients with heart failure have normal systolic, but impaired diastolic function, a condition termed heart failure with preserved ejection…
View more
Added:
3 years ago
Heart failure (HF) is a growing and increasingly important chronic disease of the Western world, occurring in at least 2% of the adult population and rising to 3% in those aged over 75 years.1 It is characterised by inadequate systemic perfusion due to impairment of the cardiac pump function. Clinical HF is a progressive condition, typically with high morbidity and mortality rates. It therefore…
View more
Added:
6 years ago
Gemma Figtree discusses the CANVAS trial - canagliflozin and heart failure in type 2 diabetes mellitus.
Filmed by Radcliffe Cardiology on-site at the American College of Cardiology congress 2018 in Orlando, USA.
View more
Added:
3 years ago
Chagas disease was initially described as an endemic health problem in a few countries in South America – mainly Argentina and Brazil – and one of the consequences of the disease, heart damage, made it an interesting issue for healthcare professionals, from epidemiologists to cardiologists.1 Chagas cardiomyopathy (ChCM) is now recognised as a cardiovascular disorder, diagnosed and treated not…
View more
Added:
3 years ago
Despite recent advances in therapy, heart failure (HF) remains a major cardiovascular epidemic worldwide. The increasing prevalence of the syndrome demands further improvement in practice and management to curb the economic and morbidity burden.
Current Dilemmas in Heart Failure Diagnosis and Care
Heart failure is a condition characterised by non-specific symptoms and unremarkable physical…
View more
Added:
3 years ago
In the first episode of our Masterclass video series, host, Dr Harriette Van Spall(McMaster University, Hamilton, CA) meets with Dr Biykem Bozkurt (Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, US), chair of the Consensus Statement on the Universal Definition and Classification of Heart Failure released by Heart Failure Society of America, Heart…
View more
« First